当前位置:
X-MOL 学术
›
Nat. Rev. Rheumatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Advancing equity in genomic medicine for rheumatology
Nature Reviews Rheumatology ( IF 29.4 ) Pub Date : 2024-08-22 , DOI: 10.1038/s41584-024-01156-y Roberto Díaz-Peña 1, 2 , Olufemi Adelowo 3
Nature Reviews Rheumatology ( IF 29.4 ) Pub Date : 2024-08-22 , DOI: 10.1038/s41584-024-01156-y Roberto Díaz-Peña 1, 2 , Olufemi Adelowo 3
Affiliation
Increasing diversity in genomic studies is essential to advance precision medicine and health equity in rheumatic diseases. Addressing structural and logistical barriers to include underrepresented populations, particularly in Africa and Latin America, could improve our understanding of rheumatic diseases and lead to better healthcare outcomes for all.
中文翻译:
促进风湿病基因组医学的公平性
增加基因组研究的多样性对于推进风湿性疾病的精准医疗和健康公平至关重要。解决结构性和后勤障碍,将代表性不足的人群纳入其中,特别是在非洲和拉丁美洲,可以提高我们对风湿病的了解,并为所有人带来更好的医疗保健结果。
更新日期:2024-08-22
中文翻译:
促进风湿病基因组医学的公平性
增加基因组研究的多样性对于推进风湿性疾病的精准医疗和健康公平至关重要。解决结构性和后勤障碍,将代表性不足的人群纳入其中,特别是在非洲和拉丁美洲,可以提高我们对风湿病的了解,并为所有人带来更好的医疗保健结果。